The relevance of PET/CT for the surgical management of neuroendocrine neoplasms

被引：0
|
作者：
Hommann, M. [1 ]
Kaemmerer, D. [1 ]
Hoersch, D. [2 ]
Kulkarni, H. R. [3 ]
Robiller, F. [3 ]
Baum, R. P. [3 ]
机构：
[1] Zent Klin Bad Berka, ENETS Ctr Excellence, Klin Allgemeine Chirurg Viszeralchirurg, D-99438 Bad Berka, Germany
[2] Zent Klin Bad Berka, ENETS Ctr Excellence, Klin Innere Med Gastroenterol Endokrinol, D-99438 Bad Berka, Germany
[3] Zent Klin Bad Berka, ENETS Ctr Excellence, Klin Mol Radiotherapie, Zentrum Mol Bildgebung, D-99438 Bad Berka, Germany
来源：
CHIRURG | 2014年 / 85卷 / 06期
关键词：
Neuroendocrine neoplasm; Somatostatin receptor; (68)Gallium; Positron emission tomography computed tomography; Surgery; TUMORS; THERAPY; THERANOSTICS; LOCALIZATION; TOMOGRAPHY; SURGERY; ANALOG;
D O I：
10.1007/s00104-013-2671-0
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
Neuroendocrine neoplasms (NEN) are rare malignancies with a wide spectrum of metastatic potential which originate from the endocrine cells of the body and express somatostatin receptors. The (68)gallium somatostatin receptor positron emission tomography-computed tomography (PET/CT) technique is the most sensitive method of assessment of well-differentiated NENs and for the detection of cancer of unknown primary (CUP syndrome) NENs. Imaging with 18F-fluorodeoxyglucose (18F-FDG PET/CT) is indicated in poorly differentiated neuroendocrine carcinomas. The receptor-dependent imaging of NENs has a decisive impact on further management.
引用
收藏
页码：500 / 504
页数：5
相关论文
共 50 条
  • [1] Bedeutung der PET/CT für die Chirurgie neuroendokriner NeoplasienThe relevance of PET/CT for the surgical management of neuroendocrine neoplasms
    M. Hommann
    D. Kaemmerer
    D. Hörsch
    H.R. Kulkarni
    F. Robiller
    R.P. Baum
    Der Chirurg, 2014, 85 : 500 - 504
  • [2] PET/CT and PET/MRI in neuroendocrine neoplasms
    Naveen Rajamohan
    Hala Khasawneh
    Aparna Singh
    Garima Suman
    Geoffrey B. Johnson
    Shounak Majumder
    Thorvardur R. Halfdanarson
    Ajit H. Goenka
    Abdominal Radiology, 2022, 47 : 4058 - 4072
  • [3] PET/CT and PET/MRI in neuroendocrine neoplasms
    Rajamohan, Naveen
    Khasawneh, Hala
    Singh, Aparna
    Suman, Garima
    Johnson, Geoffrey B.
    Majumder, Shounak
    Halfdanarson, Thorvardur R.
    Goenka, Ajit H.
    ABDOMINAL RADIOLOGY, 2022, 47 (12) : 4058 - 4072
  • [4] The Surgical Management of Lung Neuroendocrine Neoplasms
    Soldath, Patrick
    Petersen, Rene Horsleben
    CANCERS, 2023, 15 (06)
  • [5] Surgical management of pancreatic neuroendocrine neoplasms
    Partelli, Stefano
    Maurizi, Angela
    Tamburrino, Domenico
    Crippa, Stefano
    Pandolfi, Silvia
    Falconi, Massimo
    ANNALS OF SAUDI MEDICINE, 2014, 34 (01) : 1 - 5
  • [6] Surgical management of pancreatic neuroendocrine neoplasms
    Alberti, Piero
    Martin, David
    Gemenetzis, Georgios
    Parks, Rowan
    LAPAROSCOPIC ENDOSCOPIC AND ROBOTIC SURGERY, 2023, 6 (03): : 83 - 90
  • [7] Indications for the Surgical Management of Pancreatic Neuroendocrine Neoplasms
    Boesch, Florian
    Belyaev, Orlin
    Brunner, Maximilian
    Mueller-Debus, Charlotte Friederieke
    Radulova-Mauersberger, Olga
    Gruetzmann, Robert
    Keck, Tobias
    Uhl, Waldemar
    Witzigmann, Helmut
    Werner, Jens
    ZENTRALBLATT FUR CHIRURGIE, 2020, 145 (04): : 365 - 373
  • [8] Surgical Principles in the Management of Pancreatic Neuroendocrine Neoplasms
    Valentina Andreasi
    Francesca Muffatti
    Giovanni Guarneri
    Massimo Falconi
    Stefano Partelli
    Current Treatment Options in Oncology, 2020, 21
  • [9] Surgical Principles in the Management of Pancreatic Neuroendocrine Neoplasms
    Andreasi, Valentina
    Muffatti, Francesca
    Guarneri, Giovanni
    Falconi, Massimo
    Partelli, Stefano
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2020, 21 (06)
  • [10] Somatostatin Receptor Targeted PET-CT and Its Role in the Management and Theranostics of Gastroenteropancreatic Neuroendocrine Neoplasms
    Adnan, Aadil
    Basu, Sandip
    DIAGNOSTICS, 2023, 13 (13)
12345